Johan Luthman

Johan Luthman is head of R&D, including medical affairs, at Lundbeck A/S. He has transformed Lundbeck’s R&D and its pipeline, with a shift towards specialist and rare indications in neurology and psychiatry as well as changed the company’s biological research areas. Before Lundbeck, Johan led neurology development Eisai. Johan has also worked at Merck Inc, leading early neuroscience development, as CEO at GeNeuro and was leading Neurology, Immunology & Inflammation Research at MerckSerono. Johan began his pharmaceutical career at Astra/AstraZeneca in discovery, and early development.
Johan studied medicine/dentistry and obtained a Ph.D, later becoming associate professor at the Karolinska Institute.